30 Years of Innovation at ISET
1 min. read
The International Symposium on Endovascular Therapy (ISET) is celebrating its 30th anniversary on Hollywood Beach this week. Created in 1989 by Barry T. Katzen, M.D., founder and chief medical executive of Miami Cardiac & Vascular Institute, ISET is the premiere educational meeting for physicians and allied health professionals who treat patients with peripheral, cardiac and neurovascular disease.
“For nearly three decades, we have been equipping clinicians with premier endovascular education and were the pioneers of ‘live case’ education in the United States,” Dr. Katzen said. During his address at this year’s Town Hall on Innovation & the Future, Dr. Katzen stressed the importance of multidisciplinary clinical teams coming together with evolving technology to make a positive effect on the lives of patients.
(Photo: Brian E. Keeley, president and chief executive officer of Baptist Health South Florida, welcomes participants to the 30th annual ISET.)
(Photo: ‘Medical futurist’ Bertalan Meskó, M.D., Ph.D., discusses high-level drivers of change in healthcare over the next decade.)
A panel of international experts discussed how technology is changing the way cardiovascular disease will be treated over the next decade. The pros and cons of artificial intelligence (AI) were debated along with other topics like 3D medical modeling, implantable devices and patient involvement in monitoring data through applications.
(Photo: A ‘full house’ witnesses the first set of procedures live-streamed from Miami Cardiac & Vascular Institute.)
Following the town hall, a packed conference hall witnessed three live surgical procedures direct from procedure rooms at Miami Cardiac & Vascular Institute on the campus of Baptist Hospital. James F. Benenati, M.D., medical director of the noninvasive vascular laboratory at Miami Cardiac & Vascular Institute, served as moderator for the broadcast.
Healthcare that Cares
Related StoriesView All Articles
April 5, 2023
3 min. read
March 14, 2023
4 min. read
February 28, 2023
3 min. read